Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 14Sarcoma 4Genitourinary 3Other solid neoplasm 2Gastrointestinal 2Lymphoid 1Gynecologic 1

Conditions

Retinoblastoma 5Hepatoblastoma 5Sarcoma 4Wilms Tumor 3Rhabdomyosarcoma 3Rhabdoid Tumor 3Neuroblastoma 3Medulloblastoma 3Central Nervous System Neoplasms 3Carcinoma, Renal Cell 3Sarcoma, Ewing 2Pancreatic Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Neoplasm Metastasis 2Liver Neoplasms 2Kidney Neoplasms 2Brain Neoplasms 2Astrocytoma 2Testicular Neoplasms 1Teratoma 1Sarcoma, Clear Cell 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors 1Neoplasms 1Lymphoma 1

Interventions

Magnetic Resonance Spectroscopy 7Radiotherapy 6Radiosurgery 4pembrolizumab 3Specimen Handling 3Paclitaxel 3Fluorodeoxyglucose F18 3Carboplatin 3sargramostim 2cediranib 2Thiotepa 2Radiation 2Nivolumab 2Melphalan 2IFL protocol 2Granulocyte Colony-Stimulating Factor 2Genetic Testing 2Gemcitabine 2FAPI-46 2Busulfan 2130-nm albumin-bound paclitaxel 2tipifarnib 1sodium thiosulfate 1regorafenib 1paclitaxel-Angiopep-2 conjugate 1montelukast 1etoposide phosphate 1entrectinib 1entinostat 1clevudine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Brain Neoplasms × Granulocyte Colony-Stimulating Factor × Gastrointestinal × Clear all
NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡